iv dexamethasone
Drug0.15 mg/kg
Other names: Decadron
NCT Number: NCT02401529
This study aims to evaluate the effect of postoperative systemic rapid onset and short acting dexamethasone followed by a tapering dose of oral prednisolone on post-tonsillectomy morbidities. Half of the patients who comply with the inclusion criteria were selected to receive a single postoperative dose of intravenous dexamethasone followed by oral steroids; the second group received placebo.
Looking for future studies?
Notify Me5 year–20 year
All sexes
Interventional
Phase 2
The effect of preoperative systemic steroids on post-tonsillectomy morbidities such as pain, nausea, vomiting and delayed feeding was proven. However, this study aims to evaluate the effect of postoperative systemic rapid onset and short acting dexamethasone followed by a tapering dose of oral prednisolone on the aforementioned morbidities and on decreasing the duration and costs of hospital stays. patients who were in the waiting list for tonsillectomy procedure were screened for medical history and those who comply with the inclusion criteria were randomly assigned into two equal groups of 50 patients each. One group was selected to receive a single postoperative dose of intravenous dexamethasone followed by oral steroids; the second group received placebo. Questionnaires investigating postoperative pain, nausea, vomiting, and oral intake were answered by patients, parents or guardians where applicable.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
0.15 mg/kg
Other names: Decadron
0.25mg/kg/day for 7 days then tapering for next 7 days
Other names: Predosone
acetaminophen 15 mg/kg/dose every 6 hours
Other names: Adol
IV saline
Other names: Saline
Time frame: The severest pain grade felt within a week
5 grades (pain free, low disability and low intensity, low disability and high intensity, high disability and moderate intensity, high disability and severly limiting)
Time frame: number of days at which pain was experienced within the the 1st sevn days post -surgery
4 selections (1 day, 2 days, 3 days, if more specify)
Time frame: 7 days
Postoperative nausea occurence (yes, no)
Time frame: onset of 1st ocurence of nausea attack within the 1st week post-surgery
Postoperative nausea onset (no nausea, immediate, 1st day, 2nd day, 3rd day, 4th day, 5th day, 6th day, 7th day)
Time frame: 7 days
Postoperative nausea duration (no nausea,1 day, 2 days, 3 days, 4 days, if more specify)
Time frame: 7 days
Postoperative vomiting occurrence (yes, no)
Time frame: total number of post-operative vomiting episodes which were experienced within the 1st week post-surgery
Postoperative vomiting number of attacks (no vomiting,1, 2, 3, if more specify)
Time frame: Onset of 1st post-operative oral intake recorded within the 1st 3days post-surgery
feeding onset (1st day i. surgery day, 2nd day, 3rd day)
Time frame: 3 days
adequacy of meals (inadequate, adequate)
Time frame: average number of meals consumed per day for the 1st three days post-surgery
average frequency of meals (1 meal, 2 meals, if more specify)
King Fahd General Hospital
Other Gov
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03413371
Nausea, Neurologic Manifestations
Sosnowiec, Silesian Voivodeship, Poland
View Trial DetailsNCT07213687
Nausea, Neurologic Manifestations
Awasa, Snnpr, Ethiopia
View Trial DetailsNCT06609993
Aneurysm, Aortic Aneurysm
Sosnowiec, Silesian Voivodeship, Poland
View Trial DetailsNCT03874936
Agnosia, Dexamethasone
Odense, Denmark
View Trial Details